Language selection

Search

Patent 2285012 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2285012
(54) English Title: REMEDY FOR EXTERNAL APPLICATION, AND USE OF AN OIL-IN-WATER EMULSION FOR SAID REMEDY
(54) French Title: MEDICAMENT POUR APPLICATION EXTERNE ET UTILISATION D'UNE EMULSION HUILE DANS EAU POUR LEDIT MEDICAMENT
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 09/107 (2006.01)
  • A61K 09/113 (2006.01)
  • A61K 09/12 (2006.01)
  • A61K 31/015 (2006.01)
  • A61K 31/045 (2006.01)
  • A61K 31/695 (2006.01)
  • A61K 33/00 (2006.01)
(72) Inventors :
  • THONE, GERD (Germany)
(73) Owners :
  • OLIVER THONE
(71) Applicants :
  • OLIVER THONE (Germany)
(74) Agent: ROBIC AGENCE PI S.E.C./ROBIC IP AGENCY LP
(74) Associate agent:
(45) Issued: 2006-06-20
(86) PCT Filing Date: 1997-03-11
(87) Open to Public Inspection: 1997-10-02
Examination requested: 2001-11-08
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/DE1997/000476
(87) International Publication Number: DE1997000476
(85) National Entry: 1999-09-22

(30) Application Priority Data:
Application No. Country/Territory Date
196 11 742.9 (Germany) 1996-03-25

Abstracts

English Abstract


The invention relates to a remedy for external application, in particular to
prevent skin diseases. Said remedy has an oil-in-water
emulsion in which minerals are provided, the grain size thereof being so small
that the minerals can pass through the skin pores of human
skin.


French Abstract

Ce médicament pour application externe, s'utilisant en particulier contre les maladies de la peau, contient une émulsion huile dans eau, dans laquelle se trouvent des minéraux à grains si fins qu'ils peuvent passer à travers les pores de la peau humaine.

Claims

Note: Claims are shown in the official language in which they were submitted.


12
CLAIMS
1. Remedy for external application, characterized in that it comprises the
following constituents
- an oil-in-water emulsion,.and
- grained minerals which are present in ~rhe emulsion, the grain size thereof
being so small that the minerals can pass through the skin pores of human
skin.
2. Remedy according to claim 1, characterized in that the emulsion comprises
a stabilizer.
3. Remedy according to claim 2, characterized in that the stabilizer is
carboxymethylcellulose.
4. Remedy according to of claim 3, characterized in that
carboxymethylcellulose is present in a range of 0.025 to 0.75% by weight.
5. Remedy according to any one of clairns 1 to 4, characterized in that the
emulsion also comprises an antiseptic.
6. Remedy according to claim 5, characterized in that the antiseptic is tea
tree
oil.
7. Remedy according to any one of claims 5 and 6, characterized in that the
antiseptic is present in an amount between 0.001 to 1 % by weight.
8. Remedy according to any one of claims 1 to 7, characterized in that the
emulsion also comprises a surface-active agent.
9. Remedy according to claim 8, characterized in that the surface-active agent
is an anionic 15-30% surface-active agE:nt.

13
10. Remedy according to any one of claims 8 and 9, characterized in that the
surface-active agent is present in an amount between 0.0001 to 1 % by
weight.
11. Remedy according to any one of claims 1 to 10, characterized in that the
emulsion further comprises glycerine.
12. Remedy according to claim 11, characterized in that the glycerine is added
in an amount between 0.001 to 50% by weight.
13. Remedy according to any one of claims 1 to 12, characterized in that the
emulsion also comprises a fat-restoring skin milk.
14. Remedy according to claim 13, characterized in that the fat-restoring skin
milk is added in a weight range of 0.001 to 30% by weight.
15. Remedy according to any one of claims 1 to 14, characterized in that the
oil-
in-water emulsion is a mineral oil-in-water emulsion.
16. Remedy according to any one of claims 1 to 15, characterized in that the
oil-
in-water emulsion is a polydialkylsiloxane-in-water emulsion.
17. Remedy according to any one of claims 1 to 16, characterized in that the
grained minerals are amorphous pyrogenic silicic acid dissolved in oil and
emulsified in water with mineral ingredients.
18. Remedy according to claim 17, characfiarized in that the mineral
ingredients
are silicon, calcium and/or magnesium.
19. Remedy according to any one of claims 1 to 18, characterized in that it is
atomized.

14
20. Remedy according to claim 19, characterized in that, to be atomized, the
emulsion contains 0.2 - 1% by weight of mineral solution in oil, the rest is
water.
21. Use of the remedy as defined in any one of claims 1 to 20 for external
application.
22. Use of the remedy according to claim 21 wherein the external application
is
for the treatment of skin diseases.
23. Use of the remedy according to any one of claims 21 and 22, characterized
in that the remedy is applied by an atomizer.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02285012 1999-09-22
1
REMEDY FOR EXTERNAL APPLICATION, AND USE OF AN OIL-IN-WATER
EMULSION FOR SAID REMEDY
The present invention relates to a remedy for external
application, in particular for the treatment of skin
diseases, and to the use of an oil emulsion for producing
such a remedy.
A lot of remedies used to cure or relieve skin diseases
such as neurodermatitis (scabies), psoriasis (psora), acne,
dandruff, itchiness, herpes, shingles, burn wounds, scab,
sunburn and phlebalgia in the legs are well known in the
art. Not all bring satisfactory results. There is a need
for further remedies in this field.
Skin diseases like the above-mentioned are getting more
frequent. This is probably due to lots of environmental
influences and to modified environmental conditions. Skin
diseases are typically involving very troublesome accessory
symptoms. Itchiness occurs, which is often unbearable. The
disease is often aggravated or other problems occur due to
the fact that the smitten parts are too much rubbed or
scratched.
This is where the invention comes to bear. Its object is to
provide a remedy for external application, in particular
for the treatment of skin diseases, with the help of which
the clinical picture of the disease heals up soon and which
is easy to use.

i ~ ~ i
CA 02285012 2005-03-03
2
The solution of this object is to provide, on the basis of a remedy of the
type
mentioned above, an oil-in-water emulsion in which grained minerals are
provided, the grain size thereof being so small that the minerals can pass
through the skin pores of human skin, in particular amorphous, pyrogenic
silicic
acid dissolved in oil and emulsified in water with mineral ingredients like
silicon,
calcium and/or magnesium. The oil-in-water emulsion is preferably polydialkyl-
siloxane-in-water emulsion.
The decisive ingredients are the minerals contained in the
aqueous oil emulsion where they are extremely finely
dispersed. They are dispersed =so finely that their grain
size is smaller than the pore d__ameter of human skin. Thus
even the tiniest minerals may penetrate the skin. The
minerals are so tiny that they are not staying on the
surface where they would be filtered, but are absorbed by
the skin. Thus, the diseased skin gets the minerals it is
lacking.
The oil which proved most effecaive is a mineral oil. In
the mineral and oil emulsion, minerals like silicon,
calcium and traces of magnesium are extremely finely
dispersed. The emulsion is not ionogenic. The pH-value is
neutral with 5 to 7. Particular vreferred results have been
obtained when these minerals are present in an amount of
less than to by weight, prefer;~bly of less than O,lo by
weight of the emulsion. Other mi:zerals may also be present,
e.g. those belonging to the alaali and/or alkaline earth
group. The minerals are not dissolved. They are finely
dispersed.
It proved particularly preferable to add an emulsifier to the basic topical
composition. Commercial emulsifiers are used.

CA 02285012 2005-03-03
3
It proved particularly preferable to add a stabilizer to the basic topical
composition. Commercial stabilizers are used, such as for example
carboxymethylcellulose preferably used in an amount of from 0.025 to 0.75% by
weight of the total composition.
It also proved advantageous to add an anti;;eptic to the emulsion. Tea tree
oil is
particularly appropriate. On top of its antiseptic property, the composition
of tea
tree oil also soothes the skin and relieves itchiness. The antiseptic is
preferably
used in an amount of from 0.001 to 1 % by weight of the total composition.
It further proved advantageous to add a surface-active agent, in particular an
anionic surface-active agent 15 to 30%. ~~urface-active agents clean the skin
and act as emulsifiers. The surface-active agent is preferably used in an
amount
of from 0.0001 to 1 % by weight of the total composition.
It proved particularly advantageous to add glycerin to the emulsion. Glycerin
is
known as a moisture binding material for the skin. It also acts as an
emollient.
The glycerin is preferably used in an amount of from 0.001 to 50% by weight of
the total composition.
In order to confer a fat-restoring property on the remedy, a fat-restoring
additive
is added in cases in which restoring fat is desired, thus not for acne for
example.
Here, commercial compositions of skin milks for dry skin may be used. The fat-
restoring additive particularly contains oils, paraffins, stearates and so on.
The
fat-restoring skin milk is preferably used in an amount of from 0.001 to 30%
by
weight of the total composition.
Finally, the invention relates to the use of an oil-in-water emulsion
containing
finest grained minerals for producing a remedy for external application, in
particular to prevent skin diseases. In a preferred embodiment, the remedy is
so
fluid that it may be used in atomizers and sprayed on the skin. For being
atomized, the emulsion is preferably coni:aining 0.2-1 % by weight of mineral
solution in oil, the rest being water.

CA 02285012 1999-09-22
4
Tea tree oil exists in technical and pharmaceutical grades.
Both have the same effect in the remedy according to the
invention. The pharmaceutical embodiment has the advantage
to smell a little bit better.
The ingredients of 200 grams tea tree oil are typically the
following:
terpinene-4-oil 70 g
~-terpin oil 14 g
O-terpinene 46 g
~-terpinene 20 g
sigma cymene 20 g
1,8 cineole 20 g
~G-pinene 7 g
~-terpinolene 7 g
d-limonene 6 g
The remedy assists the body in self-healing. The tissue on
which the remedy was sprayed gets warm, since blood
circulation is much improved in this area. This also
contributes to heal and relieve. This is an advantage
constituting a particularity of the remedy according to the
invention. The increased blood circulation explains the
effect the remedy according to the invention has on for
example the treatment of phlebalgia.
E x a m p 1 a s
Example l:
An acne treating composition has the following ingredients:

CA 02285012 1999-09-22
5,000 g Demineralized Water
500 g Mineral Solution, emulsified in oil
200 g Tea Tree Oil
g Anionic surface-active agents 15 - 300
500 g Glycerin.
When applied on the skin, particularly when sprayed on it,
acne is healing in two stages. The already existing comedos
first dry up. Then, the skin effloresces and looks like
measles with lots of red spots. This occurs because the
10 hidden sebaceous follicles, which are not yet inflamed, are
brought to the surface of the skin. After that, the skin
becomes smooth.
Example 2:
For the production of a remedy for the treatment of
phlebalgia:
5,000 g Demineralized water
1,000 g Mineral Solution, emulsified in oil
100 g Tea Tree Oil
10 g Anionic Surface-Active Agents
1,000 g Glycerin.
After undergoing surgery on veins, the patient often
suffers from burning pain in the legs. By spraying the
fluid onto the legs, the pain vanishes. One treatment a day
is enough to remain free from pain.
Example 3:
Remedy for the treatment of neurodermatitis:

CA 02285012 1999-09-22
6
5,000 g Demineralized water
500 g Mineral Solution, emulsified in oil
200 g Tea Tree Oil
g Anionic Surface-Active Agents 15 - 300
500 g Glycerin
500 g Skin Milk for dry skin made of water, octyl
stearate, paraffin oil, castor oil, sorbitan oleate,
dimethicon tocopheryl acetate, heliotropins,
phenoxyethanol, magnesium sulphate, zinc sulphate.
The unbearable itchiness accompanying neurodermatitis eases
nearly immediately upon applying the remedy. Rubbing and
scratching as well as the constant aggravation of the
clinical picture they are causing are thus avoided. The
diseased skin parts heal very fast, actually within a few
days. The diseased, keratinized skin peels off like after
severe sunburn. It may also desquamate. The skin appearing
underneath is thin and red but normalizes very soon. It is
no longer smitten.
Example 4:
For the production of the remedy according to the
invention, formulas formulated within the following ranges
proved to be advantageous:
5,000 g Water
50-5,000 g Mineral Solution, emulsified in oil
10-2,000 g Tea Tree Oil
1-100 g Anionic Surface-Active Agents and
1-3,000 g Glycerin.

CA 02285012 1999-09-22
7
Preferred amounts of the fat-restoring additive in the
composition mentioned in Example 3are between 10 and
2, 000 g.
Example 5:
Novoskin/Dermac Amount
Water 7go
Glycerin 85% 80
Silicon sediments
Silica 2,450
Methyl Cellulose 0,050
Water 2,5%
Calcium sediments
Calcium Carbonate 0,74s
Methyl Cellulose 0,02a
Water 1,24%
Castor Oil 20
Malaleuca Oil 20
Dexpanthenol 10
Magnesium sediments
Magnesium Carbonate 0,2%
Methyl Cellulose 0,01%
Water 0,79%
Avocado Oil to
Ingredient Amount Function Standard
Water 78o Vehicle normal
Glycerin 850 8% Emollient Ph. Eur.
Purified Water 4,530 Vehicle Ph. Eur.
Colloidal Silica Anhydride 2,450 Cleanser Ph. Eur.

CA 02285012 1999-09-22
8
Castor Oil 2% Stiffener U.S.N.F.
Malaleuca Oil 2o Fragrance normal
Dexpanthenol 1o Provitamin Ph. Eur.
Avocado Oil to Fragrance normal
Potassium Carbonate 0,74% Cleanser Ph. Eur.
Magnesium Carbonate 0,2% Cleanser Ph. Eur.
Methyl Cellulose 0, 08 o Suspending
Agent Ph.
Eur.
Example 6:
Novoskin forte
Water 700
Silicon sediments
Silica 4,9%
Methyl Cellulose O,lo
Water 5%
Glycerin 850 80
Calcium sediments
Calcium Carbonate 1,480
Methyl Cellulose 0,040
Water 2,48%
Magnesium sediments
Magnesium Carbonate 0,40
Methyl Cellulose 0,02a
Water 1,58%
Castor Oil 2%
Malaleuca Oil 2%
Dexpanthenol 1s
Avocado Oil to

CA 02285012 1999-09-22
9
Ingredient Amount Function Standard
Water 70o Vehicle normal
Purified Water 9,06 Vehicle Ph. Eur.
o
Glycerin 85% 8% Emollient Ph. Eur.
Colloidal Silica Anhydride 4,9% Cleanser Ph. Eur.
Castor Oil 2s Stiffener U.S.N.F.
Malaleuca Oil 2% Fragrance normal
Potassium Carbonate 1,48% Cleanser Ph. Eur.
Dexpanthenol to Provitamin Ph. Eur.
Avocado Oil to Fragrance normal
Magnesium Carbonate 0,4s Cleanser Ph. Eur.
Methyl Cellulose 0,16% Suspending
Agent Ph.
Eur.
Example 7:
Novoskin mild
Water 80 0
Glycerin 850 80
Silicon sediments
Silica 2,45s
Methyl Cellulose 0,050
Water 2,50
Calcium sediments
Calcium Carbonate 0,740
Methyl Cellulose 0,02%
Water 1,24%
Castor Oil 20
Dexpanthenol to
Magnesium sediments
Magnesium Carbonate 0,20
Methyl Cellulose O,Olo
Water 1,79%

CA 02285012 1999-09-22
Avocado Oil 1~
Ingredient Amount Function Standard
Water 80o Vehicle normal
Glycerin 85% 8o Emollient Ph. Eur.
Purified Water 4,53% Vehicle Ph. Eur.
Colloidal Silica Anhydride 2,45% Cleanser Ph. Eur.
Castor Oil 2o Stiffener U.S.N.F.
10 Dexpanthenol 1o Provitamin Ph. Eur.
Avocado Oil 1% Fragrance normal
Potassium Carbonate 0,740 Cleanser Ph. Eur.
Magnesium Carbonate 0,2o Cleanser Ph. Eur.
Methyl Cellulose 0,080 Suspending
Agent Ph.
Eur.
The water used may be distilled water or water containing
the following ingredients:
Sodium 5,4 mg/1 or ppm
Potassium 1,1 mg/1 or ppm
Magnesium 24,6 mg/1 or ppm
Calcium 49,8 mg/1 or ppm
Chlorides 11,4 mg/1 or ppm
Sulphate 7,1 mg/1 or ppm
Hydrogen Carbonate 253,0 mg/1 or ppm
Example 8:
Composition of the oil emulsion with minerals

CA 02285012 1999-09-22
11
38 % solids, final size of grain of the minerals in the
range between 1 and 100 nanometres, preferably between 1
and 10 nanometres.
- = Quartz Powder, initial size 5 micrometres
30 20%
5 30 14% DolomiteBrick Powder, initial size 2 micrometres
- =
1 10 = Magnesium Powder approximately 3 micrometres
- 3%
O1 5 = Methyl Cellulose
- 1%
10 60 = Castor Oil, Pharmagrad
- 38%
2 40 = Water
- 22%
10 This blend is first kneaded intensively in a kneading
machine at a temperature of approximately 50°C. Then, it is
brought - inline - to a colloid mill. The colloid mill has
a cross gearing with a device for pumping aver and rotor
cooling. In a slow passage, the minerals are ground to the
size of 10-9 m. The castor oil emulsifies in the warm water
and is stabilized by methyl cellulose. In order to avoid
overheating during grinding, it is necessary to cool the
grinding body. The thus obtained mineral and oil emulsion
is stable and may be further diluted with water and
blended.

Representative Drawing

Sorry, the representative drawing for patent document number 2285012 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2015-01-01
Time Limit for Reversal Expired 2013-03-11
Letter Sent 2012-03-12
Inactive: IPC deactivated 2011-07-29
Inactive: Correspondence - MF 2010-08-10
Inactive: Late MF processed 2010-03-29
Letter Sent 2010-03-11
Letter Sent 2006-11-27
Inactive: Payment - Insufficient fee 2006-11-27
Inactive: Office letter 2006-11-22
Inactive: Entity size changed 2006-11-22
Final Fee Paid and Application Reinstated 2006-11-07
Inactive: Corrective payment - s.78.6 Act 2006-11-07
Grant by Issuance 2006-06-20
Inactive: Cover page published 2006-06-19
Inactive: Final fee received 2006-04-04
Pre-grant 2006-04-04
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2006-03-13
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Notice of Allowance is Issued 2006-02-10
Letter Sent 2006-02-10
Notice of Allowance is Issued 2006-02-10
Inactive: Approved for allowance (AFA) 2005-09-26
Amendment Received - Voluntary Amendment 2005-03-22
Amendment Received - Voluntary Amendment 2005-03-03
Inactive: S.30(2) Rules - Examiner requisition 2004-12-22
Amendment Received - Voluntary Amendment 2004-06-30
Inactive: S.30(2) Rules - Examiner requisition 2004-04-30
Letter Sent 2001-12-21
All Requirements for Examination Determined Compliant 2001-11-08
Request for Examination Requirements Determined Compliant 2001-11-08
Request for Examination Received 2001-11-08
Letter Sent 2000-04-11
Letter Sent 2000-04-11
Inactive: Single transfer 2000-02-29
Inactive: IPC assigned 1999-11-24
Inactive: IPC assigned 1999-11-24
Inactive: IPC assigned 1999-11-24
Inactive: Cover page published 1999-11-23
Inactive: IPC assigned 1999-11-16
Inactive: IPC assigned 1999-11-16
Inactive: First IPC assigned 1999-11-16
Inactive: Courtesy letter - Evidence 1999-11-02
Inactive: Notice - National entry - No RFE 1999-10-29
Application Received - PCT 1999-10-26
Inactive: Applicant deleted 1999-10-26
Application Published (Open to Public Inspection) 1997-10-02

Abandonment History

Abandonment Date Reason Reinstatement Date
2006-03-13

Maintenance Fee

The last payment was received on 2005-12-14

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
OLIVER THONE
Past Owners on Record
GERD THONE
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1999-09-21 1 53
Description 1999-09-21 11 295
Claims 1999-09-21 2 65
Claims 2004-06-29 3 91
Description 2005-03-02 11 311
Claims 2005-03-02 3 73
Notice of National Entry 1999-10-28 1 193
Courtesy - Certificate of registration (related document(s)) 2000-04-10 1 113
Courtesy - Certificate of registration (related document(s)) 2000-04-10 1 113
Reminder - Request for Examination 2001-11-13 1 118
Acknowledgement of Request for Examination 2001-12-20 1 178
Commissioner's Notice - Application Found Allowable 2006-02-09 1 162
Courtesy - Abandonment Letter (Maintenance Fee) 2006-11-22 1 175
Notice of Reinstatement 2006-11-26 1 165
Maintenance Fee Notice 2010-04-21 1 170
Late Payment Acknowledgement 2010-04-21 1 163
Late Payment Acknowledgement 2010-04-21 1 163
Maintenance Fee Notice 2012-04-22 1 171
Correspondence 1999-10-28 1 15
PCT 1999-09-21 11 363
Correspondence 2000-02-28 3 95
Fees 2003-03-03 1 28
Fees 2002-02-21 1 32
Fees 2000-03-01 1 29
Fees 2001-02-26 1 32
Fees 2004-02-22 1 28
Fees 2005-03-10 2 42
Fees 2005-12-13 1 30
Correspondence 2006-04-03 1 29
Fees 2006-11-06 2 80
Correspondence 2006-11-21 1 17
Correspondence 2010-08-09 1 46
Correspondence 2012-04-22 1 72